Emtricitabine-tenofovir
Two-drug HIV backbone and daily HIV prevention pill (PrEP).
- Starts working
- PrEP: protection builds over 7–20 days
- Half-life
- Emtricitabine about 10 hours; tenofovir about 17 hours (intracellular days)
- In use since
- —
- Pregnancy
- Generally considered safe
Overview
This combination tablet is the standard backbone of HIV treatment and the most widely used pill for pre-exposure prophylaxis (PrEP). When used for PrEP, regular HIV testing and kidney checks are required.
Conditions it's used for
How it works
Blocks HIV from copying itself, in treatment or prevention.
Emtricitabine-tenofovir belongs to the Nucleos(t)ide reverse transcriptase inhibitors. How Nucleos(t)ide reverse transcriptase inhibitors work: act as faulty building blocks that stop the virus copying its genetic material into DNA.
Uses
- HIV pre-exposure prophylaxis
- HIV infection (with a third drug)
- Post-exposure prophylaxis (with a third drug)
Available as: tablet.
Typical dose
- Adults
- One tablet (emtricitabine 200 mg/tenofovir disoproxil 300 mg) once a day.
Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.
Side effects
Common
Often mild and may settle with time
- Nausea
- Headache
- Diarrhoea
- Tiredness
Serious — get medical help
Uncommon, but need prompt attention
- Kidney problems
- Bone density loss
- Hepatitis B flare on stopping
- Lactic acidosis (rare)
Warnings
- Test for HIV and hepatitis B first
- Check kidney function before and during use
Who should avoid it
- Unknown HIV status for PrEP (test first)
- Creatinine clearance under 30 mL/min
- Taking lamivudine
Interactions
- NSAIDs, aminoglycosides — kidney damage
- Other hepatitis B or HIV nucleoside drugs — duplicate effect
Other medicines in the atlas that need care with Emtricitabine-tenofovir, grouped by the reason:
Combined kidney toxicityModerateWith Aceclofenac, Amikacin, Amphotericin B, Aspirin, Bleomycin and 22 more
Both medicines can damage the kidneys; together the risk is higher.
What's usually done: Kidney function is usually monitored; maintain hydration.
Using it safely
- Alcohol
- Best to limit. Alcohol adds to liver and kidney strain.
- Food and drink
- With or without food.
- If you miss a dose
- Take when remembered; for PrEP follow your prescriber's advice on extra protection.
- Stopping it
- Do not stop without advice, particularly with hepatitis B.
- Driving
- Dizziness is possible.
- Tests and checks
- HIV test every 3 months for PrEP; Kidney function; Hepatitis B status
- If too much is taken
- Kidney problems; seek advice.
- Storage
- Room temperature.
- Legal status
- United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule HAustralia: Prescription only (Schedule 4)
Pregnancy and breastfeeding
Pregnancy
Generally considered safe
Used in pregnancy for HIV treatment and PrEP.
Breastfeeding
Use with caution
Passes into milk in small amounts; consult your clinic.
Special groups
- Kidney disease
- Not recommended below 30 mL/min.
- Older adults
- Check kidney function.
Brand names
- United States
- Truvada, Descovy
- United Kingdom
- Truvada
- India
- Truvada, Tenvir-EM
- Australia
- Truvada
Examples only; many generic versions exist. The same brand name can mean different products in different countries.
Common questions
Do I need a prescription for Emtricitabine-tenofovir?
Yes — Emtricitabine-tenofovir is prescription-only in most countries.
Can I take Emtricitabine-tenofovir during pregnancy?
Generally considered safe. Used in pregnancy for HIV treatment and PrEP. Always check with a doctor or midwife.
How quickly does Emtricitabine-tenofovir work?
PrEP: protection builds over 7–20 days.
Related medicines
Tenofovir disoproxil
Backbone drug for HIV treatment, PrEP and hepatitis B.
RxWHONucleos(t)ide reverse transcriptase inhibitorsLamivudine
Backbone antiretroviral also active against hepatitis B.
RxWHONucleos(t)ide reverse transcriptase inhibitorsDolutegravir
Core of the WHO-preferred HIV treatment.
RxWHOIntegrase inhibitorsAbacavir
NRTI with a serious HLA-B*5701 hypersensitivity warning.
RxWHONucleos(t)ide reverse transcriptase inhibitorsEntecavir
First-line antiviral for chronic hepatitis B.
RxWHONucleos(t)ide reverse transcriptase inhibitorsZidovudine
The first HIV drug, still used to prevent mother-to-child transmission.
RxWHONucleos(t)ide reverse transcriptase inhibitors
Sources and official information
- MedlinePlus (US National Library of Medicine)
- DailyMed — official US labels
- NHS medicines A–Z
- WHO ATC/DDD index — J05AR03
Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.